ClinConnect ClinConnect Logo
Search / Trial NCT03933124

The Effect of Virtual Reality on Post-surgical Pain and Recovery.

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Apr 29, 2019

Trial Information

Current as of May 06, 2025

Completed

Keywords

Post Surgical Pain Virtual Reality Distraction

ClinConnect Summary

Adequate management of post-surgical pain (PSP) may contribute to improved clinical and socioeconomic outcomes. Facilitating an adequate level of PSP relief is a challenging problem: the analgesics that are most frequently used, for example, opioids and non-steroidal anti-inflammatory drugs (NSAIDs), often come with side effects and do not always provide sufficient pain relief. Therefore, pain management is increasingly focusing on (additional) non-pharmacological analgesics, including Virtual Reality (VR).

VR immerses the user in a virtual world through a head mounted device (HMD). VR is,...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient underwent surgery
  • Patient reports a postoperative pain score ≥4 on the first postoperative day at the surgical ward and pain score should also be marked with 'pain is not acceptable'.
  • At the day of recruitment, the estimated length of stay is at least 4 days after inclusion.
  • Patient is willing and able to comply with the trial protocol.
  • Patient is at least 16 years old on the day the informed consent form will be signed.
  • Exclusion Criteria:
  • Patient suffers from delirium or acute confusional state.
  • Patient has (a history of) dementia, seizure or epilepsy.
  • Patient with severe hearing/visual impairment not corrected.
  • Patient is placed in isolation.
  • The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
  • Unplanned (re)admission to the intensive care unit (ICU).
  • Inclusion in another trial to evaluate new ways of treating pain

About Radboud University Medical Center

Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.

Locations

Nijmegen, , Netherlands

Patients applied

0 patients applied

Trial Officials

Harry van Goor, MD,PhD,FRCS

Principal Investigator

Radboud University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials